Launched in 2010, Mérieux Développement is the healthcare growth capital investment vehicle of Institut Mérieux.
Mérieux Développement invests in the healthcare sector at an international level, working alongside entrepreneurs whose products and services can bring genuine advances to the health of patients and consumers worldwide, offering them access to its industry expertise and global network.
Mérieux Développement is based in France (Lyon) with a presence in the United States (Boston and California).
Mérieux Développement intends to create value as an active investor and targets a balanced portfolio across sub-sectors, geographies and maturity stage (early and late stage). Targeted sectors include life science, healthcare and well being (human or animal health, nutrition or wellness segments). Mérieux Développement is focused on equity investments of €5 million to €20 million, typically for a minority stake.
Mérieux Développement works alongside entrepreneurs whose products and services can bring genuine advances to the health of patients and consumers worldwide. Merieux Developpement is the investment arm of Institut Mérieux, which employs 15,000 people worldwide and generated revenues in excess of USD 3 billion in 2017.
Sienna Capital & Mérieux Développement
In 2014, Sienna Capital committed an amount of EUR 75 million dedicated to the two funds managed by Mérieux Développement: Mérieux Participations I and Mérieux Participations 2. Sienna Capital benefits from certain favourable financial terms for its support of Mérieux Participations 2.
Financial year 2017
In 2017, Mérieux Participations 2 has invested in 4 new companies for a total amount of EUR 26 million.
Value of investment
EUR 60 million (30/06/2018)